Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
1987-7-31
pubmed:abstractText
Vancomycin is a narrow-spectrum antibiotic that has concentration-dependent efficacy and toxicity. Recent literature indicates that orally administered activated charcoal can enhance the clearance of intravenously administered drugs. To evaluate the effects of activated charcoal on vancomycin clearance, six healthy male volunteers received vancomycin (1 g) intravenously with and without activated charcoal coadministration. In a randomized crossover sequence, subjects were given 50 g of activated charcoal immediately before the vancomycin infusion was begun and 15 g at 2, 4, 6, and 8 h afterwards, or an equal volume of water. Multiple doses of charcoal did not have a statistically significant effect on any pharmacokinetic parameter for vancomycin. Mean control values +/- standard deviation for vancomycin clearance, elimination half-life, and 24-h urinary recovery were 6.4 +/- 1.0 liters/h, 6.6 +/- 1.5 h, and 856 +/- 116 mg, respectively. Mean values for the same parameters were 6.4 +/- 1.0 liters/h, 6.0 +/- 0.9 h, and 897 +/- 130 mg when activated charcoal was given. We conclude that multiple doses of orally administered activated charcoal do not enhance vancomycin clearance in subjects with normal renal function when serum concentrations are within the therapeutic range. The results of this investigation cannot be extrapolated to patients with toxic vancomycin concentrations or renal dysfunction. The use of activated charcoal in these populations warrants further study.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/3606073-13370625, http://linkedlifedata.com/resource/pubmed/commentcorrection/3606073-13425364, http://linkedlifedata.com/resource/pubmed/commentcorrection/3606073-13542649, http://linkedlifedata.com/resource/pubmed/commentcorrection/3606073-2987139, http://linkedlifedata.com/resource/pubmed/commentcorrection/3606073-3516107, http://linkedlifedata.com/resource/pubmed/commentcorrection/3606073-352213, http://linkedlifedata.com/resource/pubmed/commentcorrection/3606073-3757406, http://linkedlifedata.com/resource/pubmed/commentcorrection/3606073-3933714, http://linkedlifedata.com/resource/pubmed/commentcorrection/3606073-4026495, http://linkedlifedata.com/resource/pubmed/commentcorrection/3606073-4085353, http://linkedlifedata.com/resource/pubmed/commentcorrection/3606073-6101256, http://linkedlifedata.com/resource/pubmed/commentcorrection/3606073-6337763, http://linkedlifedata.com/resource/pubmed/commentcorrection/3606073-6499360, http://linkedlifedata.com/resource/pubmed/commentcorrection/3606073-6627827, http://linkedlifedata.com/resource/pubmed/commentcorrection/3606073-6697647, http://linkedlifedata.com/resource/pubmed/commentcorrection/3606073-6732213, http://linkedlifedata.com/resource/pubmed/commentcorrection/3606073-6732227, http://linkedlifedata.com/resource/pubmed/commentcorrection/3606073-7050705, http://linkedlifedata.com/resource/pubmed/commentcorrection/3606073-7083219, http://linkedlifedata.com/resource/pubmed/commentcorrection/3606073-7110218, http://linkedlifedata.com/resource/pubmed/commentcorrection/3606073-7371700
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
0066-4804
pubmed:author
pubmed:issnType
Print
pubmed:volume
31
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
720-2
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1987
pubmed:articleTitle
Effect of orally administered activated charcoal on vancomycin clearance.
pubmed:publicationType
Journal Article, Clinical Trial, Research Support, U.S. Gov't, P.H.S., Randomized Controlled Trial